Market News

Boston Advisors Has Trimmed Vanda Pharmaceuticals Com (VNDA) Stake By $323,680; Harris Associates LP Raised By $647,942 Its Howard Hughes (HHC) Position

Harris Associates LP increased Howard Hughes Corp (HHC) stake by 0.34% reported in 2017Q2 SEC filing. Harris Associates LP acquired 5,311 shares as Howard Hughes Corp (HHC)’s stock rose 10.78%. The Harris Associates LP holds 1.59M shares with $194.76M value, up from 1.58M last quarter. Howard Hughes Corp now has $5.37B valuation. The stock increased 0.13% or $0.16 during the last trading session, reaching $124.16. About 103,366 shares traded. The Howard Hughes Corporation (NYSE:HHC) has risen 25.50% since December 4, 2016 and is uptrending. It has outperformed by 8.80% the S&P500.

Boston Advisors Llc decreased Vanda Pharmaceuticals Inc Com (VNDA) stake by 56.07% reported in 2017Q2 SEC filing. Boston Advisors Llc sold 20,230 shares as Vanda Pharmaceuticals Inc Com (VNDA)’s stock declined 5.00%. The Boston Advisors Llc holds 15,850 shares with $258,000 value, down from 36,080 last quarter. Vanda Pharmaceuticals Inc Com now has $633.48M valuation. The stock increased 1.62% or $0.23 during the last trading session, reaching $14.1. About 12,475 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 51.60% since December 4, 2016 and is uptrending. It has outperformed by 34.90% the S&P500.

Analysts await Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) to report earnings on February, 21. They expect $-0.09 EPS, down 325.00% or $0.13 from last year’s $0.04 per share. After $-0.10 actual EPS reported by Vanda Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts -10.00% EPS growth.

Boston Advisors Llc increased Disney Walt Co Com Disney (NYSE:DIS) stake by 156,372 shares to 541,991 valued at $57.59M in 2017Q2. It also upped Unitedhealth Group Inc Com (NYSE:UNH) stake by 11,568 shares and now owns 372,031 shares. Cardinal Health Inc Com (NYSE:CAH) was raised too.

Among 7 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 19 analyst reports since September 2, 2015 according to SRatingsIntel. Piper Jaffray maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rating on Wednesday, September 2. Piper Jaffray has “Buy” rating and $16 target. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) earned “Buy” rating by Piper Jaffray on Tuesday, June 27. H.C. Wainwright maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rating on Thursday, August 3. H.C. Wainwright has “Buy” rating and $1800 target. On Thursday, October 6 the stock rating was reinitiated by Jefferies with “Buy”. Jefferies maintained the shares of VNDA in report on Monday, June 26 with “Buy” rating. The firm has “Buy” rating given on Thursday, October 19 by Piper Jaffray. JMP Securities maintained the stock with “Market Outperform” rating in Friday, August 26 report. The company was maintained on Wednesday, March 9 by JMP Securities. As per Monday, September 4, the company rating was maintained by Jefferies. The rating was maintained by Oppenheimer on Monday, October 30 with “Outperform”.

Investors sentiment increased to 1.17 in 2017 Q2. Its up 0.19, from 0.98 in 2017Q1. It improved, as 13 investors sold VNDA shares while 39 reduced holdings. 19 funds opened positions while 42 raised stakes. 37.25 million shares or 3.45% less from 38.58 million shares in 2017Q1 were reported. Matarin Llc reported 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Bancshares Of Montreal Can stated it has 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Trexquant LP owns 23,568 shares for 0.11% of their portfolio. Cap One Association holds 0.02% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) for 18,953 shares. Royal Commercial Bank Of Canada has invested 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Point72 Asset Limited Partnership stated it has 1.94 million shares or 0.18% of all its holdings. Clarivest Asset Mngmt Lc stated it has 5,767 shares. 36,919 were accumulated by Parametric Ltd Co. Panagora Asset Management stated it has 0.01% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Northern stated it has 0% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Kistler reported 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Ajo LP owns 541,927 shares for 0.04% of their portfolio. Secor Advsrs Limited Partnership owns 121,138 shares or 0.18% of their US portfolio. Gemmer Asset Mgmt Limited Liability Com owns 594 shares or 0% of their US portfolio. Armistice Ltd has 4.29% invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA).

Among 7 analysts covering Howard Hughes (NYSE:HHC), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Howard Hughes had 11 analyst reports since August 14, 2015 according to SRatingsIntel. Compass Point maintained the stock with “Buy” rating in Monday, May 23 report. The firm has “Sell” rating given on Thursday, September 24 by TheStreet. The stock of The Howard Hughes Corporation (NYSE:HHC) earned “Market Outperform” rating by CJS Securities on Monday, October 31. Compass Point maintained the shares of HHC in report on Tuesday, December 8 with “Buy” rating. The stock has “Hold” rating by Sandler O’Neill on Thursday, March 30. On Thursday, June 8 the stock rating was initiated by BWS Financial with “Buy”. As per Wednesday, August 10, the company rating was maintained by Citigroup. On Friday, May 13 the stock rating was initiated by Citigroup with “Buy”. The firm has “Buy” rating given on Sunday, August 16 by JMP Securities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *